glp 1 fda ban moves to remove GLP-1 medications from 503B Bulks List FDA Proposes Ban on Bulk

Discover what happens if you miss a dose of tirzepatide and how to handle it safely

If you want to know how to lose weight or burn fat, it can feel like an uphill battle, even with a consistent diet and exercise

Pharma and telehealth weight loss drug players should also provide transparent data on how many people experience which side effects when taking a GLP-1, while working with social media platforms to flag misleading content about medication efficacy and safety.

The GLP-1 market is led by semaglutide products Ozempic and Wegovy (Novo Nordisk) and tirzepatide products Mounjaro and Zepbound (Lilly)

Revisit the 2025 Orlando congress, where clinicians, researchers, nutritionists, and policymakers shared advances in obesity prevention, treatment, and care.